GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Atomo Diagnostics AT1.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.01

-6.67%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Atomo Diagnostics — daily ASX:AT1

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Atomo Diagnostics on TradingView ↗
Market value
A$11.3m
Last close × shares
Volume
20.8m
Shares, 9 Nov 2026

About Atomo Diagnostics

Its shares trade on ASX under the ticker AT1.AX. It has been listed since 16 April 2020. In the fiscal year to 30 June 2026, it reported revenue of A$5.3m and a net loss of A$3.5m. At that date it held total assets of A$10.8m and shareholders' equity of A$7.7m.

Atomo Diagnostics Ltd. engages in manufacturing, research, development, and design of in-vitro medical devices for blood-based rapid diagnostic testing (RDT) for professional use and self-testing. The firm supplies integrated rapid diagnostic test (RDT) devices to the global diagnostic market. The Company’s patented devices simplify testing procedures, enhance usability and improve reliability across rapid point-of-care (POC) and at-home testing applications. The firm has commercialized a number of products across international markets and has supply agreements in place for testing applications targeting infectious diseases, including COVID-19, HIV, viral vs bacterial differentiation and female health. Its products include Atomo HIV Self-Test, AtomoRapid HIV (1&2) and ATOMONOW Pregnancy Test. Its Atomo HIV Self-Test is an integrated, blood-based rapid diagnostic test (RDT) for HIV screening, which provides results in 15 minutes. Its AtomoRapid HIV (1&2) integrates multiple test components into the device platform. AtomoRapid HIV (1&2) needs a small drop of blood to give results in 15 minutes.

Figures and description from our data supplier, not checked against the company's own report.

More about Atomo Diagnostics →

Latest on Atomo Diagnostics

Our reporting

We have not reported on Atomo Diagnostics yet.

Next results

24 Feb 2027

Due on 24 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Atomo Diagnostics's ticker?

Atomo Diagnostics trades as AT1.AX on ASX, under ISIN AU0000080327.

What was Atomo Diagnostics's last closing price?

0.01 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Atomo Diagnostics next report results?

Results are expected on 24 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.